n Southern African Journal of HIV Medicine - FDA Public advisory for Nevirapine (Viramune) : public health

Volume 2005, Issue 18
  • ISSN : 1608-9693
  • E-ISSN: 2078-6751



Extracted from text ... MARCH 2005 THE SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE 10 FDA Public advisory for Nevirapine (Viramune) PUBLIC HEALTH Recently the US Federal Drug Administration has issued a Public Advisory for Nevirapine (NVP) (Vira-mune) informing health care providers of a safety-related change to the nevirapine package insert. This advisory, issued on 19 January 2005, notified a change in nevirapine prescribing information with a warning against starting nevirapine in women with CD4 counts > 250 cells/?l and in men with counts > 400/?l. The risk of developing a hepatic hypersensitivity reaction in the first 6 weeks of nevirapine therapy had been shown ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error